The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this metabolic disorder, but Vogenx aims to stand apart by offering patients a different mechanism of action and oral dosing. The post Vogenx IPO Raises $81M for Trial in Metabolic Disease With No…
Celcuity drug Revtorpyk is now approved for advanced cases of the most common type of breast cancer that do not harbor a certain mutation. The intravenously infused medicine is first in a new drug class that addresses a pathway associated with many cancers. The post Celcuity’s First-in-Class Drug Gets FDA Approval in Most Common Type…
Leaders from West Virginia-based Hawse Health report progress after implementing AI‑assisted documentation
Whether trying to see more patients, retain more staff, expand the organization’s technology stack or bring more dollars in the door, it’s not uncommon for professionals to want to maximize their resources amidst a market influx. The post Want to Maximize Rev Cycle Efficiencies? Here are 3 Considerations appeared first on MedCity News.
Patient trust, physician credibility, and payer goodwill are not soft considerations alongside the balance sheet; they are the mechanism by which a pharmaceutical product generates revenue over time. The post Ethics Isn’t a Pharma Value — It’s a Competitive Moat appeared first on MedCity News.
A direct-to-patient model for observational research will ease the participation burden, better incorporate the patient voice, and empower individuals to take control of their health – all while meeting the growing demands for robust evidence in developing new drugs and therapeutics. The post A Tailor-made Approach to Simplify Observational Research appeared first on MedCity News.
This issue brief discusses key changes to immigration policies that may take place under the second Trump administration based on his previous record and campaign statements, and their implications.
Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic…
During his first news conference as Health and Human Services secretary, Robert F. Kennedy Jr. on April 16 ticked off things he thinks kids with autism will never do, including paying taxes, holding a job, and going on a date. Kennedy’s comments go against science and reality. This slide presentation first appeared on KFF Health…